ArticleDiabetes care2017

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325-331.

Muhammad Abdul-Ghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.